Stay updated on Pembrolizumab and Radiotherapy in Melanoma: Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab and Radiotherapy in Melanoma: Clinical Trial page.
Latest updates to the Pembrolizumab and Radiotherapy in Melanoma: Clinical Trial page
- Check3 days agoChange DetectedThe website has updated the 'type of intervention' feature from version v2.13.3 to v2.14.0, indicating a significant change in this functionality.SummaryDifference0.2%
- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoNo Change Detected
- Check32 days agoChange DetectedThe website has been updated from version 2.13.2 to 2.13.3.SummaryDifference0.1%
- Check39 days agoChange DetectedThe website has updated the contact details section for the study, clarifying that it now provides information for individuals who can answer questions about joining the study, along with the study's location.SummaryDifference2%
- Check53 days agoChange DetectedThe website has added new features for user interaction while removing extensive details about participant groups, interventions, and various data fields available for download.SummaryDifference3%
- Check60 days agoChange DetectedSeveral key health-related URLs have been removed, including those from MedlinePlus and NIH, which may impact access to information on genetics and specific diseases.SummaryDifference0.5%
- Check68 days agoChange DetectedThe website has been updated to version 2.12.2, with numerous new links added related to genetics, melanoma, rare diseases, and clinical trials, while the previous version 2.12.1 has been removed.SummaryDifference4%
Stay in the know with updates to Pembrolizumab and Radiotherapy in Melanoma: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab and Radiotherapy in Melanoma: Clinical Trial page.